Skip to main content
logo
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
10.91
+0.10 (0.93%)
At close: Nov 5, 2025, 4:00 PM EST
10.92
+0.01 (0.09%)
After-hours: Nov 5, 2025, 4:10 PM EST

Enanta Pharmaceuticals Revenue

Enanta Pharmaceuticals had revenue of $18.31M in the quarter ending June 30, 2025, with 1.91% growth. This brings the company's revenue in the last twelve months to $64.81M, down -9.94% year-over-year. In the fiscal year ending September 30, 2024, Enanta Pharmaceuticals had annual revenue of $67.64M, down -14.61%.

Revenue (ttm)
$64.81M
Revenue Growth
-9.94%
P/S Ratio
3.59
Revenue / Employee
$494,702
Employees
131
Market Cap
304.43M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202467.64M-11.57M-14.61%
Sep 30, 202379.20M-6.96M-8.07%
Sep 30, 202286.16M-10.91M-11.24%
Sep 30, 202197.07M-25.40M-20.74%
Sep 30, 2020122.47M-82.72M-40.31%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca56.50B
Novartis AG56.37B
Novo Nordisk49.11B
Revenue Rankings

ENTA News

More News